<DOC>
	<DOCNO>NCT00310596</DOCNO>
	<brief_summary>The purpose study determine effect Magnevist ( gadopentetate dimeglumine ) injection way heart conduct electrical impulse allow beat effectively . The study compare Magnevist injection 's effect placebo ( saline injection ) .</brief_summary>
	<brief_title>Cardiovascular Safety Study MagnevistÂ® Injection Two Dose Levels Two Injection Rates Normal Subjects</brief_title>
	<detailed_description>This study previously post Berlex , Inc. Berlex , Inc. rename Bayer HealthCare Pharmaceuticals , Inc.Bayer HealthCare Pharmaceuticals , Inc.is sponsor trial .</detailed_description>
	<mesh_term>Moxifloxacin</mesh_term>
	<mesh_term>Norgestimate , ethinyl estradiol drug combination</mesh_term>
	<criteria>Subjects electrocardiogram [ ECG ] ( normal sinus rhythm [ SR ] , QTc &gt; 450 msec ) without clinically significant abnormality Nonsmoker History cardiovascular disease Pregnant nursing Had contraindication moxifloxacin</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>ECG safety</keyword>
</DOC>